1 Introduction Immunotherapy has achieved notable success in clinical practice with the development of various immunogenic therapeutic agents [1-4]. However, its efficacy is often constrained by the immunosuppressive tumor microenvironment. In recent years, the cyclic GMP–AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway has emerged as a key mediator of immunogenic responses, offering considerable potential to enhance antitumor immunity.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile